A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Pfizer
Nammi Therapeutics Inc
Janssen Research & Development, LLC
Bayer
Turning Point Therapeutics, Inc.
GlaxoSmithKline
Revolution Medicines, Inc.
AstraZeneca
Merck Sharp & Dohme LLC
Varian, a Siemens Healthineers Company
Pilatus Biosciences Inc
Revolution Medicines, Inc.
DualityBio Inc.
Zhejiang Doer Biologics Co., Ltd.
Shanghai Juncell Therapeutics
GlaxoSmithKline
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Revolution Medicines, Inc.
Revolution Medicines, Inc.
RefleXion Medical
Marengo Therapeutics, Inc.
Mirai Medical
Binhui Biopharmaceutical Co., Ltd.
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
Shanghai Yunying Medical Technology